Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-21 Purchase | 2024-10-23 7:53 pm | Inhibikase Therapeutics Inc. | IKT | Bellini Roberto Director | 1,460,000 | $1.37 | $2,000,200 | 1,520,000 (Indirect Direct) | View |
| 2024-10-21 Purchase | 2024-10-23 7:49 pm | Inhibikase Therapeutics Inc. | IKT | Kush Arvind Director | 145,000 | $1.37 | $198,650 | 205,000 (Direct) | View |
| 2024-10-21 Purchase | 2024-10-23 7:43 pm | Inhibikase Therapeutics Inc. | IKT | Munshi Amit Director | 365,000 | $1.37 | $500,050 | 425,000 (Indirect Direct) | View |
| 2022-08-16 Purchase | 2022-08-16 4:25 pm | Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner | 5,000 | $0.8 | $4,000 | 5,335,433 (Direct) | View |
| 2022-05-27 Purchase | 2022-05-31 10:16 am | Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner | 5,000 | $0.976 | $4,880 | 5,330,433 (Direct) | View |
| 2022-05-20 Purchase | 2022-05-23 4:57 pm | Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner | 10,000 | $0.6 | $6,000 | 5,325,433 (Direct) | View |
| 2022-05-19 Purchase | 2022-05-23 4:54 pm | Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer | 3,948 | $0.644 | $2,543 | 48,091 (Direct) | View |
| 2021-11-17 Purchase | 2021-11-19 08:13 am | Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner | 23,589 | $1.9737 | $46,558 | 5,317,169 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-10-25 5:52 pm | N/A N/A | Inhibikase Therapeutics Inc. | IKT | Sands Capital Life Sciences Pulse Fund II L.P. Sands Capital Ventures LLC SANDS FRANK M. 10% Owner | 0 | $0 | 10,950,000 (Direct) | View |
| 2024-10-21 Option Award | 2024-10-23 7:58 pm | N/A 2034-10-21 | Inhibikase Therapeutics Inc. | IKT | Canner David Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-10-21 Option Award | 2024-10-23 7:53 pm | N/A 2034-10-21 | Inhibikase Therapeutics Inc. | IKT | Bellini Roberto Director | 60,000 | $0 | 1,520,000 (Direct) | View |
| 2024-10-21 Option Award | 2024-10-23 7:49 pm | N/A 2034-10-21 | Inhibikase Therapeutics Inc. | IKT | Kush Arvind Director | 60,000 | $0 | 205,000 (Direct) | View |
| 2024-10-21 Option Award | 2024-10-23 7:43 pm | N/A 2034-10-21 | Inhibikase Therapeutics Inc. | IKT | Munshi Amit Director | 60,000 | $0 | 425,000 (Direct) | View |
| 2024-07-16 Option Award | 2024-07-18 5:27 pm | N/A 2031-07-16 | Inhibikase Therapeutics Inc. | IKT | GRINT PAUL C Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-07-16 Option Award | 2024-07-18 5:23 pm | N/A 2031-07-16 | Inhibikase Therapeutics Inc. | IKT | Dion Gisele Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-07-16 Option Award | 2024-07-18 5:20 pm | N/A 2031-07-16 | Inhibikase Therapeutics Inc. | IKT | BERMAN DENNIS N Director | 30,000 | $0 | 30,000 (Indirect) | View |
| 2024-07-16 Option Award | 2024-07-18 5:18 pm | N/A 2031-07-16 | Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 4:47 pm | N/A 2031-04-01 | Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner | 45,000 | $0 | 45,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-02 5:14 pm | N/A 2031-04-01 | Inhibikase Therapeutics Inc. | IKT | Lees-Rolfe Garth Chief Financial Officer | 90,000 | $0 | 90,000 (Direct) | View |
Ownership | 2024-04-02 5:12 pm | N/A 2029-11-28 | Inhibikase Therapeutics Inc. | IKT | Lees-Rolfe Garth Chief Financial Officer | 0 | $0 | 5,834 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 9:18 pm | N/A 2030-06-30 | Inhibikase Therapeutics Inc. | IKT | BERMAN DENNIS N Director | 6,667 | $0 | 6,667 (Indirect) | View |
| 2023-06-30 Option Award | 2023-07-05 9:16 pm | N/A 2030-06-30 | Inhibikase Therapeutics Inc. | IKT | Dion Gisele Director | 6,667 | $0 | 6,667 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 9:12 pm | N/A 2033-06-30 | Inhibikase Therapeutics Inc. | IKT | GRINT PAUL C Director | 6,667 | $0 | 6,667 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 9:11 pm | N/A 2030-06-30 | Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director | 6,667 | $0 | 6,667 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:00 pm | N/A 2030-03-01 | Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner | 210,000 | $0 | 210,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:00 pm | N/A 2023-03-01 | Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Cheif Financial Officer | 90,000 | $0 | 138,091 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 5:08 pm | N/A 2032-09-01 | Inhibikase Therapeutics Inc. | IKT | Dion Gisele Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 9:00 pm | N/A 2029-06-24 | Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 9:00 pm | N/A 2029-06-24 | Inhibikase Therapeutics Inc. | IKT | GRINT PAUL C Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 9:00 pm | N/A 2029-06-24 | Inhibikase Therapeutics Inc. | IKT | O'Farrell Elizabeth G. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 9:00 pm | N/A 2029-06-24 | Inhibikase Therapeutics Inc. | IKT | BERMAN DENNIS N Director | 40,000 | $0 | 40,000 (Indirect) | View |
| 2022-03-07 Option Award | 2022-03-21 4:05 pm | N/A 2029-03-07 | Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer | 62,500 | $0 | 106,643 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-21 4:05 pm | N/A 2029-03-07 | Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner | 125,000 | $0 | 5,440,433 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-09 8:22 pm | N/A 2029-03-07 | Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Cheif Financial Officer | 62,500 | $0 | 106,643 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-09 8:21 pm | N/A 2029-03-07 | Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner | 125,000 | $0 | 5,440,433 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-04 9:25 pm | N/A 2025-03-01 | Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner | 21,853 | $0 | 5,315,433 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-04 9:25 pm | N/A N/A | Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner | 21,853 | $2.02 | 5,315,433 (Direct) | View |
| 2021-08-17 Exercise | 2021-08-19 07:46 am | N/A 2023-06-01 | Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner | 21,853 | $0 | 5,293,580 (Direct) | View |
| 2021-08-17 Exercise | 2021-08-19 07:46 am | N/A N/A | Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner | 21,853 | $2.02 | 5,293,580 (Direct) | View |
| 2021-06-25 Option Award | 2021-06-29 7:12 pm | 2022-06-25 2028-06-25 | Inhibikase Therapeutics Inc. | IKT | O'Farrell Elizabeth G. Director | 22,677 | $0 | 22,677 (Direct) | View |